Exatecan derivatives, linker-payloads, and conjugates and thereof

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 11999748
APP PUB NO 20240018159A1
SERIAL NO

18453748

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present disclosure relates to the biopharmaceutical field, in particular, Exatecan derivatives, linker-payloads, and conjugates and thereof antibody-drug conjugates, and the corresponding preparing process and use thereof.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

  • GENEQUANTUM HEALTHCARE (SUZHOU) CO. LTD.

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Chen, Guangming Shanghai, CN 58 1013
Hu, Mingyu Suzhou, CN 10 4
Qin, Gang Suzhou, CN 32 105
Song, Paul H Suzhou, CN 10 8
Zhang, Tony Yantao Shanghai, CN 22 29
Zhong, Boyu Shanghai, CN 22 48

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
3.5 Year Payment $1600.00 $800.00 $400.00 Dec 4, 2027
7.5 Year Payment $3600.00 $1800.00 $900.00 Dec 4, 2031
11.5 Year Payment $7400.00 $3700.00 $1850.00 Dec 4, 2035
Fee Large entity fee small entity fee micro entity fee
Surcharge - 3.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00